Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析

◆英語タイトル:Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH136492FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Merrimack Pharmaceuticals Inc (MACK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes novel targeted solutions for the treatment of various types of cancers through its understanding of biological markers and cancer pathways. The company’s first commercial product was Onivyde (irinotecan liposome injection), a liposomal formulation for treating advanced pancreatic cancer patients. Merrimack is entitled to receive milestone payments related to sale of Onivyde and MM-436 to Ipsen SA. Merrimack is headquartered in Cambridge, Massachusetts, the US.

Merrimack Pharmaceuticals Inc Key Recent Developments

Nov 05,2020: Merrimack reports third quarter 2020 financial results
Aug 07,2020: Merrimack reports second quarter 2020 financial results
May 07,2020: Merrimack reports first quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Merrimack Pharmaceuticals Inc – Key Facts
Merrimack Pharmaceuticals Inc – Key Employees
Merrimack Pharmaceuticals Inc – Key Employee Biographies
Merrimack Pharmaceuticals Inc – Major Products and Services
Merrimack Pharmaceuticals Inc – History
Merrimack Pharmaceuticals Inc – Company Statement
Merrimack Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Merrimack Pharmaceuticals Inc – Business Description
Merrimack Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Merrimack Pharmaceuticals Inc – Strengths
Merrimack Pharmaceuticals Inc – Weaknesses
Merrimack Pharmaceuticals Inc – Opportunities
Merrimack Pharmaceuticals Inc – Threats
Merrimack Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Merrimack Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 05, 2020: Merrimack reports third quarter 2020 financial results
Aug 07, 2020: Merrimack reports second quarter 2020 financial results
May 07, 2020: Merrimack reports first quarter 2020 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Merrimack Pharmaceuticals Inc, Key Facts
Merrimack Pharmaceuticals Inc, Key Employees
Merrimack Pharmaceuticals Inc, Key Employee Biographies
Merrimack Pharmaceuticals Inc, Major Products and Services
Merrimack Pharmaceuticals Inc, History
Merrimack Pharmaceuticals Inc, Subsidiaries
Merrimack Pharmaceuticals Inc, Key Competitors
Merrimack Pharmaceuticals Inc, Ratios based on current share price
Merrimack Pharmaceuticals Inc, Annual Ratios
Merrimack Pharmaceuticals Inc, Annual Ratios (Cont...1)
Merrimack Pharmaceuticals Inc, Interim Ratios
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Merrimack Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Utah Medical Products Inc (UTMD):企業の財務・戦略的SWOT分析
    Summary Utah Medical Products Inc (Utah Medical) is a medical device company that offers disposable and reusable products. The company offers blood pressure monitoring and blood management, gynecology, perinatology, urology and electrosurgery, respiratory and OEM products. Its blood pressure monitor …
  • Apollo Education Group Inc:企業の戦略的SWOT分析
    Apollo Education Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Puretech Health plc (PRTC):企業の財務・戦略的SWOT分析
    Summary Puretech Health Plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunction in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug can …
  • Spark Capital:企業のM&A・事業提携・投資動向
    Spark Capital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spark Capital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Sun BioPharma Inc (SNBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • Sutures India Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Sutures India Private Limited (SIPL) is a medical device company that manufactures and markets surgical sutures. The company provides absorbable sutures, surgical tape, surgical mesh, bone wax, nonabsorbable sutures, skin stapler and surgical gloves. Its absorbable sutures include plain catg …
  • United Parcel Service Inc (UPS):企業の財務・戦略的SWOT分析
    United Parcel Service Inc (UPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • P/F Atlantic Petroleum (ATLA DKK):企業の財務・戦略的SWOT分析
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • Berry Global Group Inc:企業の戦略・SWOT・財務分析
    Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CaroGen Corp-製薬・医療分野:企業M&A・提携分析
    Summary CaroGen Corp (CaroGen) is a vaccine company that offers platform technology development services. The company develops and commercializes nanoparticle therapeutic vaccines. It utilizes its virus-like vesicle platform technology, a proprietary replication competent to develop nano particle th …
  • Tangent Energy Solutions, Inc.:企業の戦略的SWOT分析
    Tangent Energy Solutions, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Snap-on Incorporated:戦略・SWOT・企業財務分析
    Snap-on Incorporated - Strategy, SWOT and Corporate Finance Report Summary Snap-on Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Oxford Gene Technology Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford Gene Technology Ltd (OGT) is a provider of genetics research solutions. The company’s products comprise fish probes, custom cancer panels, custom AML panel, custom breast cancer panel, custom FH panel, core MPN panel, ovarian cancer panel, myeloid panel and others. It provides medical …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ansvar Insurance Limited:企業の戦略・SWOT・財務分析
    Ansvar Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary Ansvar Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fauji Fertilizer Bin Qasim Ltd (FFBL):電力:M&Aディール及び事業提携情報
    Summary Fauji Fertilizer Bin Qasim Ltd (FFBL) is a chemical manufacturing company that manufactures, supplies and markets di ammonium phosphate (DAP) and granular urea. In addition, the company undertakes production and marketing of ammonia and other nitrogenous fertilizers for agricultural applicat …
  • CSX Corp (CSX):企業の財務・戦略的SWOT分析
    CSX Corp (CSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Ascendance Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company’s products include human HepatoMune kits, HepatoPac B-CLEAR transporter kits, human HepatoPac kits, rat HepatoPac kits, monkey HepatoPac kits …
  • ICICI Prudential Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    ICICI Prudential Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary ICICI Prudential Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Le Chateau Inc. (CTU):企業の財務・戦略的SWOT分析
    Le Chateau Inc. (CTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆